Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_2

25%

Ph phase_4

50%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

2(50.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (25.0%)

Phase 42 (50.0%)

N/A1 (25.0%)

Trials by Status

completed375%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

terminatedphase_2

Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study

NCT01934192

completedphase_4

Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

NCT02314351

completedphase_4

The Montefiore Metoclopramide Study

NCT00475306

completednot_applicable

Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide

NCT01069536

Clinical Trials (4)

Showing 4 of 4 trials

NCT01934192Phase 2

Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study

Terminated

NCT02314351Phase 4

Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

Completed

NCT00475306Phase 4

The Montefiore Metoclopramide Study

Completed

NCT01069536Not Applicable

Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4